FOXO Technologies Inc (FOXO) USD0.0001 A
- Add to watchlist
- This stock can be held in a
Business summary
FOXO Technologies Inc. is a biotechnology company. The Company is focused on improving human health and longevity through the development of cutting-edge technology and product solutions for various industries, including life insurance. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. Its FOXO Labs segment performs research and development and is commercializing proprietary epigenetic biomarker technology. Its concentrating efforts on Bioinformatics Services offering, a suite of bioinformatic tools to help researchers process, analyze, and interpret epigenetic data and research and development in the fields of health and wellness testing powered by machine learning and AI (including a potential AI platform for the delivery of health and well-being data-driven insights to individuals, healthcare professionals and third-party service providers).
Contact details
Important dates
General stock information
- Short code:
- FOXO
- ISIN:
- US3514713052
- Market cap:
- $2.43 million
- Shares in issue:
- 13.63 million
- Sector:
- Application Software
- Exchange:
- -
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.